Results for Q1 2019
Results the first three months of fiscal year 2019 were announced on May 16. Conference call details
Join our team
Contribute to a highly skilled team who is passionate about changing lives. Learn more
Dual-hormone pump
Learn more about the iLet™ from our partner Beta Bionics. View video
Meet 3 SBS patients
Learn more about Short Bowel Syndrome (SBS) from three Danish patients. View video
Our research
Applying our peptide platform to specialty disease areas to invent novel therapies.
Read more
Late-stage pipeline
Advancing fully owned development programs with Phase 3 in two rare disease programs. See our pipeline
Shareholder portal
As a shareholder, you can access a wide range of investor information.
Read more
Severe hypoglycemia
A daily struggle to live
with SBS
Annual Report
2018
